150 related articles for article (PubMed ID: 3697784)
1. Apomorphine and haloperidol effects on striatal 3H-dopamine release in anesthetized, awake restrained and freely moving rats.
Spampinato U; Girault JA; Danguir J; Savaki HE; Glowinski J; Besson MJ
Brain Res Bull; 1986 Feb; 16(2):161-6. PubMed ID: 3697784
[TBL] [Abstract][Full Text] [Related]
2. Release of newly synthesized 3H-dopamine in the striatum: an adaptation of the push-pull cannula method to awake restrained and anesthetized rats.
Savaki HE; Girault JA; Spampinato U; Truong NA; Glowinski J; Besson MJ
Brain Res Bull; 1986 Feb; 16(2):149-54. PubMed ID: 3697783
[TBL] [Abstract][Full Text] [Related]
3. Brain tyrosine depletion attenuates haloperidol-induced striatal dopamine release in vivo and augments haloperidol-induced catalepsy in the rat.
Jaskiw GE; Bongiovanni R
Psychopharmacology (Berl); 2004 Feb; 172(1):100-7. PubMed ID: 14586541
[TBL] [Abstract][Full Text] [Related]
4. Apomorphine does not reverse reduced basal dopamine release in rat striatum and nucleus accumbens after chronic haloperidol treatment.
Ichikawa J; Meltzer HY
Brain Res; 1990 Jan; 507(1):138-42. PubMed ID: 2302571
[TBL] [Abstract][Full Text] [Related]
5. [The effect of halothane anesthesia on dopamine release induced by apomorphine or haloperidol--an in vivo microdialysis study in rats striatum].
Adachi Y; Wada H; Higuchi H; Watanabe K; Satoh T
Masui; 2001 Oct; 50(10):1089-95. PubMed ID: 11712340
[TBL] [Abstract][Full Text] [Related]
6. Alterations in dopamine release from striatal slices of rats after chronic treatment with haloperidol.
Yamada S; Yokoo H; Harajiri S; Nishi S
Eur J Pharmacol; 1991 Jan; 192(1):141-5. PubMed ID: 2040357
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1991 Jan; 256(1):348-57. PubMed ID: 1703232
[TBL] [Abstract][Full Text] [Related]
8. 8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release.
Lucas G; Bonhomme N; De Deurwaerdère P; Le Moal M; Spampinato U
Psychopharmacology (Berl); 1997 May; 131(1):57-63. PubMed ID: 9181636
[TBL] [Abstract][Full Text] [Related]
9. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
Agut J; Coviella IL; Wurtman RJ
Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
[TBL] [Abstract][Full Text] [Related]
10. Effects of buspirone on dopamine dependent behaviours in rats.
Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
[TBL] [Abstract][Full Text] [Related]
11. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
[No Abstract] [Full Text] [Related]
12. Effects of cholecystokinin octapeptide on striatal dopamine metabolism and on apomorphine-induced stereotyped cage-climbing in mice.
Kovács GL; Szabó G; Penke B; Telegdy G
Eur J Pharmacol; 1981 Jan; 69(3):313-9. PubMed ID: 6260512
[TBL] [Abstract][Full Text] [Related]
13. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
Dismukes K; Mulder AH
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
Saller CF; Salama AI
Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
[TBL] [Abstract][Full Text] [Related]
15. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
Bettini E; Ceci A; Spinelli R; Samanin R
Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
[TBL] [Abstract][Full Text] [Related]
16. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
17. The effect of apomorphine and bradykinin on uptake and release of dopamine in vitro by striatal synaptosomes of the rat.
Borawska M; Wiśniewski K
Pol J Pharmacol Pharm; 1982; 34(1-3):79-84. PubMed ID: 7167424
[TBL] [Abstract][Full Text] [Related]
18. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
Lipska BK; Weinberger DR
Brain Res Dev Brain Res; 1993 Oct; 75(2):213-22. PubMed ID: 7903225
[TBL] [Abstract][Full Text] [Related]
19. Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.
Fà M; Mereu G; Ghiglieri V; Meloni A; Salis P; Gessa GL
Synapse; 2003 Apr; 48(1):1-9. PubMed ID: 12557266
[TBL] [Abstract][Full Text] [Related]
20. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
